SPARC: A potential diagnostic marker of invasive meningiomas

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 237-241

  Rempel, Sandra A ^a   Ge, Shugang ^a   Gutiérrez, Jorge A ^a  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

HUMANS; IMMUNOHISTOCHEMISTRY; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM INVASIVENESS; OSTEONECTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033014199     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kepes, J. J. Meningiomas. Biology, Pathology, and Differential Diagnosis. In: Stephen S. Sternberg (ed.), Masson Monographs in Diagnostic Pathology, p. 1-2. New York: Masson Publishing USA, Inc., 1982.
2. Weber, R. G., Boström, J., Wolter, M., Baudis, M., Collins, V. P., Reifenberger, G., and Lichter, P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc. Natl. Acad. Sci. USA, 94: 14719-14724, 1997.
3. Rempel, S. A. Molecular biology of central nervous system tumors. Curr. Opin. Oncol., 10: 179-185, 1998.
4. Russell, D. S., and Rubenstein, L. J. Pathology of the Tumors of the Nervous System, Ed. 5, pp. 1-1012. London: Edward Arnold, 1989.
5. Kleihues, P., Burger, P. C., and Scheithauer, B. W. The new WHO classification of brain tumors. Brain Pathol., 3: 255-268, 1993.
6. Sage, E. H. Terms of attachment: SPARC and tumorigenicity. Nat. Med., 3: 144-146, 1997.
7. Mundlos, S., Schwahn, B., Reichert, T., and Zabel, B. Distribution of osteonectin mRNA and protein during human embryonic and fetal development. J. Histochem. Cytochem., 40: 283-291, 1992.
8. ++ -binding EF-hand. J. Cell. Biochem., 57: 341-350, 1995.
9. Rosenblatt, S., Bassuk, J. A., Alpers, C. E., Sage, E. H., Tirnpl, R., and Preissner, K. T. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem. J., 324: 311-319, 1997.
10. Rempel, S. A., Golembieski, W. A., Ge, S., Lemke, N., Elisevich, K., Mikkelsen, T., and Gutiérrez, J. A. SPARC. A Signal of Astrocytic Neoplastic Transformation and Reactive Response in Human Primary and Xenograft Gliomas. J. Neuropathol. Exp., Neurol., 57: 1112-1121, 1998.
11. Nakasu, S., Hirano, A., Llena, J. F., Shimura, T., and Handa, J. Interface between the meningioma and the brain. Surg. Neurol., 32: 206-212, 1989.
12. Porter, P. L., Sage, E. H., Lane, T. F., Funk, S. E., and Gown, A. M. Distribution of SPARC in normal and neoplastic tissue. J. Histochem. Cytochem., 43: 791-800, 1995.
13. Bellacene, A., and Castronovo, V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am. J. Pathol., 146: 95-100, 1995.
14. Porte, H., Chastre, E., Prevot, S., Nordlinger, B., Empereur, S., Basset, P., Chambon, P., and Gespach, C. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int. J. Cancer, 64: 70-75, 1995.
15. Nefussi, J. R., Brami, G., Modrowski, D., Oboeuf, M., and Forest, N. Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro. J. Histochem. Cytochem., 45: 493-503, 1997.